Skip to main content
. 2012 Nov 15;42(1):93–100. doi: 10.3892/ijo.2012.1699

Figure 2.

Figure 2.

Figure 2.

Figure 2.

Figure 2.

Figure 2.

Figure 2.

ROC curves of the serum anti-IGFBP-2 antibodies, CEA, CYFRA21-1 and NSE in discriminating between controls and patients with lung cancer. (A–D) ROC curves of the serum anti-IGFBP-2 antibodies, CEA, CYFRA21-1 and NSE; (E) ROC curves of the serum anti-IGFBP-2 antibodies in discriminating lung cancer I–II; (F) ROC curves of the serum anti-IGFBP-2 antibodies in discriminating lung cancer III–IV. CI, confidence interval.